SCHEMBL3346686

SCHEMBL3346686

Cc1cc(-c2ccc(Cl)c(C(N)=O)c2)n[nH]1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 2/20 0.57
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.46
ALOX5 P09917 4/20 0.45
ALOX5AP P20292 4/20 0.45
FEN1 P39748 4/20 0.45
ALK Q9UM73 1/20 0.44
PRMT5 O14744 1/20 0.44
WDR77 Q9BQA1 1/20 0.44
ALPL P05186 4/20 0.41
CA9 Q16790 1/20 0.41
CASP1 P29466 1/20 0.41
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP19A1 P11511 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
CA12 O43570 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4471895 0.88 P2RX7 (0.57) P2RX7NPC1RAB9ASMN1; SMN2L3MBTL1
SCHEMBL3342192 0.87 ALPL (0.49) P2RX7NPC1RAB9ASMN1; SMN2L3MBTL1
SCHEMBL14966653 0.86 P2RX7 (0.64) P2RX7NPC1RAB9ASMN1; SMN2L3MBTL1
SCHEMBL4462430 0.85 P2RX7 (0.56) P2RX7NPC1RAB9ASMN1; SMN2L3MBTL1
SCHEMBL14965792 0.82 ALPL (0.56) P2RX7NPC1RAB9ASMN1; SMN2L3MBTL1
SCHEMBL3346696 0.78 NPC1 (0.53) P2RX7NPC1RAB9ASMN1; SMN2L3MBTL1
SCHEMBL3345938 0.75 KDM4E (0.44) P2RX7NPC1L3MBTL1ALOX5ALOX5AP
SCHEMBL4469098 0.75 P2RX7 (0.52) P2RX7NPC1RAB9ASMN1; SMN2L3MBTL1
SCHEMBL5799212 0.74 P2RX7 (0.59) P2RX7NPC1RAB9ASMN1; SMN2ALOX5
SCHEMBL4460890 0.73 P2RX7 (0.58) P2RX7ALOX5ALOX5APFEN1NTRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS ROCHE PALO ALTO LLC 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100160384-A1 DIHYDROPYRIDONE AMIDES AS P2X7 MODULATORS P2RY1, P2RX6, P2RX3 P2RX7 8/4885NPC1 1906/4885RAB9A 1850/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.